|
C1ORF172 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.813000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.836400E-01 |
| Normal-vs-Stage2 |
9.337500E-02 |
| Normal-vs-Stage3 |
6.905600E-01 |
| Normal-vs-Stage4 |
6.298200E-01 |
| Stage1-vs-Stage2 |
2.560000E-01 |
| Stage1-vs-Stage3 |
3.959000E-01 |
| Stage1-vs-Stage4 |
6.773800E-01 |
| Stage2-vs-Stage3 |
1.005990E-01 |
| Stage2-vs-Stage4 |
2.396000E-01 |
| Stage3-vs-Stage4 |
8.442600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.829800E-01 |
| Normal-vs-AfricanAmerican |
3.603600E-01 |
| Normal-vs-Asian |
2.740400E-01 |
| Caucasian-vs-AfricanAmerican |
6.648800E-01 |
| Caucasian-vs-Asian |
6.348400E-01 |
| AfricanAmerican-vs-Asian |
9.364800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.842800E-01 |
| Normal-vs-Female |
2.763000E-01 |
| Male-vs-Female |
8.992400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.255000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.891410E-01 |
| Normal-vs-Age(61-80Yrs) |
5.005800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.273000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.493000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.140200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.714000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.460400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.647600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.811200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.265200E-01 |
| Classical-VS-Follicular |
6.638600E-01 |
| Classical-VS-Other |
5.000400E-01 |
| Classical-VS-Normal |
2.250800E-01 |
| Tall-VS-Follicular |
1.401760E-01 |
| Tall-VS-Other |
1.875990E-01 |
| Tall-VS-Normal |
6.629800E-01 |
| Follicular-VS-Other |
6.770600E-01 |
| Follicular-VS-Normal |
2.237400E-01 |
| Other-VS-Normal |
3.123000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.118840E-01 |
| Normal-vs-N1 |
5.644800E-01 |
| N0-vs-N1 |
1.994450E-02 |
|
|
